The spread of smartphones in places like rural Africa is tantalizing to NGOs and funders who see new ways to solve tough problems. Here's a look at an idea exciting enough to spur pledges of $50 million.
Marie Stopes International, a top player in the field of women's health, has been hard hit by Trump's re-imposition of the Global Gag Rule. We get an inside look at how it's trying to adapt and find new funding.
Food companies have a history of using funding research that minimizes the health risks of their products. They're still doing it—in developing countries where obesity is rising fast.
GiveWell, the charity evaluator, believes that most gifts achieve little impact. Its push to redirect donor dollars is making headway—even as the limits of its approach have also become clearer.
Around 2 billion people worldwide suffer from some form of malnutrition, which can have devastating long-term effects on children. We look at how top funders are mobilizing around this issue.
NTDs don't inflict the kind of death toll of better known diseases like malaria, but they have devastating effects on poor countries. Here's another sign that private philanthropy is stepping up the fight against them.
In Europe, three of the largest charitable organizations on the continent are joining together to focus on "understudied challenges of global relevance." Which means what, exactly?
Don't throw up your hands. In fact, many heroic groups are engaged in high-impact work to save and improve lives in poor countries—often flying beneath the radar. Hilton has made a point of spotlighting them.
Trump's reimposition of the Global Gag Rule set off a worldwide scramble to find new funds for critical programs that provide reproductive health services for women in poor countries. Who's stepping up?
Cardiovascular diseases are the number one cause of death worldwide. But these and similar noncommunicable diseases tend to be overlooked by funders. Here's another sign this may be changing.
It’s been cool to see a top foundation throw open its doors to any and all ideas, as MacArthur has done with its offer of a single $100 million grant. But this drawn out competition has also sent a wrong message.
Ted Turner's $1 billion pledge to U.N. causes in 1997 ushered in a new era of big philanthropy. Twenty years later, we look at what this gift achieved.
The maker of Marlboro cigarettes pledged about $1 billion to a new foundation dedicated to ending smoking worldwide. Why is it so hard to take this move seriously?
The pharmaceutical company, AmerisourceBergen, started its own grantmaking foundation just two years ago. To get a better sense of it's priorities, we connected with the foundation’s president, Gina Clark.
Diarrheal diseases, often caused by poor sanitation, are the second leading cause of death for children under the age of five in poor countries. Which explains why Gates is sticking with its quest for a better toilet.
Let's stop buying the excuse that top philanthropists can’t find smart ways to give away more of their wealth—and start pushing them harder to give more and give now.
With the Trump administration working to cut U.S. support for global family planning services, advocates and funders are in crisis mode. Gates is giving much more. Who else is joining in?
As Bloomberg expands his global health funding with a new focus on reducing deaths from non-communicable diseases, his foundation wants to help more cities embrace proven interventions.
In an era of uncertain federal commitments, how can philanthropy refocus its energies on what remains a profound global health crisis? We talk to the leaders of Funders Concerned About AIDS.
There have only been five cases of polio to date this year and the virus has been eliminated in all but three countries. Still, funders are doubling down to finish the job, putting up $1.2 billion.
With his annual giving now over $600 million, Bloomberg hopes to spread his no-nonsense ideas for improving global health–namely, by looking beyond trendy causes to "overlooked killers."
Clubfoot doesn’t get a lot of attention from global health funders. But one major grantmaker is stepping up here in a big way: the Oak Foundation.
Antibiotic-resistant superbugs are killing ever more people in a trend that could have dire consequences. No funder is more worried about this threat than Wellcome Trust.
In another example of Bloomberg Philanthropies zeroing in on mundane but vital global health issues, the foundation is ramping up its work to prevent drowning deaths in poor countries.
Chicagoland couple Jerry and Susan Kolschowsky, who built a fortune in the food industry, support the poor and hungry near home—and in the developing world.
Continuing our spotlight of new grantmaking action on NTDs, we look at which funders are putting up funds to combat the devastating parasitic disease schistosomiasis.
Derek C. Schrier founded Indaba Capital Management, where he's managing partner. But a major component of his philanthropy with wife Cameron involves South Africa, where Schrier worked to end apartheid.
Neglected tropical diseases inflict a devastating human and economic toll on poor countries. The good news? It’s been a busy year in the global fight against NTDs.
Providing continuous access to essential medicines is a global health challenge where innovation is key—especially where the critical cold chain is concerned. Microneedles are one solution.